Immunotherapy in Pediatric Hematologic Malignant Neoplasms
نویسندگان
چکیده
منابع مشابه
Insect bite-like reaction in patients with hematologic malignant neoplasms.
BACKGROUND Exaggerated reaction to insect bites, mainly to mosquitoes, is infrequently described in patients with chronic lymphocytic leukemia. Skin lesions usually appear months to years after the diagnosis of leukemia and are unrelated to laboratory findings, disease course, or therapy. OBSERVATIONS We describe 8 patients with various hematologic disorders (chronic lymphocytic leukemia, acu...
متن کاملNQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
BACKGROUND AND OBJECTIVES NAD(P)H:quinone oxidoreductase 1 (NQO1) is an enzyme that protects cells against mutagenicity from free radicals and toxic oxygen metabolites. The gene coding for NQO1 is subject to a genetic polymorphism at nucleotide position 609 (C-->T) of the human NQO1 cDNA. Heterozygous individuals (C/T) have intermediate activity and homozygotes for the variant allele (T/T) are ...
متن کاملSubsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.
BACKGROUND Most prior studies evaluating subsequent malignant neoplasms (SMNs) in patients with neuroblastoma are restricted to long-term survivors and/or their treatment exposures. This study investigates SMNs in patients diagnosed with neuroblastoma at our institution. METHODS Records of 646 patients treated for neuroblastoma at St Jude Children's Research Hospital between 1961 and 2005 wer...
متن کاملImmunotherapy of hematologic malignancy.
Over the past few years, improved understanding of the molecular basis of interactions between antigen presenting cells and effector cells and advances in informatics have both led to the identification of many candidate antigens that are targets for immunotherapy. However, while immunotherapy has successfully eradicated relapsed hematologic malignancy after allogeneic transplant as well as vir...
متن کاملTerminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
The presence of terminal deoxynucleotidyl transferase (TdT) has been determined in neoplastic cells from 50 patients with non-hematologic tumors as well as neoplastic cells from 85 patients with hematologic malignancies. The results indicate that TdT is not present in cells from non-hematologic tumors, Hodgkin's lymphoma, B cell lymphoproliferative disorders, peripheral T cell neoplasms, reacti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Pediatric Hematology-Oncology
سال: 2020
ISSN: 2233-5250,2233-4580
DOI: 10.15264/cpho.2020.27.1.14